Cargando…
JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial
BACKGROUND: Pre-diabetes is a growing health concern where a large percentage of these patients develop full type 2 diabetes. Effective interventions on pre-diabetes can prevent or delay the occurrence or development of diabetes. Pharmaco-dynamics and pre-clinical of JinQi-Jiangtang tablets (JQJT) s...
Autores principales: | Cao, Hongbo, Ren, Ming, Guo, Liping, Shang, Hongcai, Zhang, Junhua, Song, Yuzhen, Wang, Hui, Wang, Baohe, Li, Xiantao, Hu, Jing, Wang, Xuemei, Wang, Dehui, Chen, Jianzong, Li, Shuanglei, Chen, Liming |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842259/ https://www.ncbi.nlm.nih.gov/pubmed/20214831 http://dx.doi.org/10.1186/1745-6215-11-27 |
Ejemplares similares
-
JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial
por: Wang, Hui, et al.
Publicado: (2017) -
The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design
por: Sun, Xiao, et al.
Publicado: (2015) -
JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice
por: Cao, Ying, et al.
Publicado: (2019) -
The Hypoglycemic Effect of JinQi Jiangtang Tablets Is Partially Dependent on the Palmatine-Induced Activation of the Fibroblast Growth Factor Receptor 1 Signaling Pathway
por: Li, Siming, et al.
Publicado: (2022) -
Renoprotective effect of JinQi-JiangTang tablet on high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats
por: Jiang, Bingjie, et al.
Publicado: (2018)